Curis to Present at MASS Opportunities: A Biotechnology Investment Conference
Thursday October 23, 9:17 am ET
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 23, 2003--Curis, Inc. (NASDAQ: CRIS - News) announced today that Marc Charette, Ph.D., Curis' Vice President for Corporate Communications, will speak at the upcoming MASS Opportunities: A Biotechnology Investment Conference being held at the Logan Airport Hilton in Boston, Massachusetts on October 27-28, 2003. Dr. Charette's presentation is scheduled for 3:40 PM on Monday, October 27. Dr. Charette will present an update on Curis' business model and a review of its therapeutic product development programs.
A live audio webcast will be available on the Curis website at www.curis.com/webcast. The replay of the webcast will be available approximately one hour after the presentation and archived for ninety days.
The MASS Opportunities conference, which is annually sponsored by the Massachusetts Biotechnology Council, is a New England-based forum that provides more than 70 private and public biotechnology firms with an opportunity to showcase their technologies and products in front of portfolio managers, analysts, venture capitalists, and other investment professionals. In 2002, the event attracted over 800 participants.
About Curis, Inc.
Curis, Inc. is a therapeutic drug development company. The Company's technology focus is on regulatory pathways that control repair and regeneration. Curis' product development involves the use of proteins or small molecules to modulate these pathways. Curis has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of kidney disease, neurological disorders, cancer, and alopecia (hair loss). For more information, please visit the Curis web site at www.curis.com.
Contact:
For Curis, Inc.
Christopher U. Missling, Ph.D., 617-503-6587
or
Marc F. Charette, Ph.D., 617-503-6629
Source: Curis, Inc. |
